Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Nanotech Guidance Takes Small Step Forward

This article was originally published in The Tan Sheet

Executive Summary

FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.
Advertisement

Related Content

FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group
Proposed Spray Sunscreen Warnings A Gateway For Nano Tort Litigation?
CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology
Synthetics Stance In NDI Guidance Raises Red Flag For Industry
Badger Reformulates Sunscreens To Meet Nano-Free Demand
Badger Reformulates Sunscreens To Meet Nano-Free Demand
U.S., European Nanotech Programs Move Regulations Closer To Global Model
Nano-Engineered Products Are Not GRAS-Ready - Experts
Advisory Committee Split On Whether FDA Should Draft Nanotech Guidance
Nanotech Report’s Recommendations Unsettling To Supplement Industry

Topics

Advertisement
UsernamePublicRestriction

Register

PS105108

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel